Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence

Figure 2

Progression-free survival hazard ratios across subgroups. Abbreviations: chemo: chemotherapy, DFI: disease-free interval, ER: estrogen receptor, PgR: progesterone receptor.